Get the Stockscreener App
2.35
2.08%
-0.05
After Hours:
2.35
InspireMD Inc. stock is traded at $2.35, with a volume of 36,866.
It is down -2.08% in the last 24 hours and down -2.08% over the past month.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See More
Previous Close:
$2.40
Open:
$2.42
24h Volume:
36,866
Relative Volume:
0.37
Market Cap:
$98.04M
Revenue:
$6.21M
Net Income/Loss:
$-19.92M
P/E Ratio:
-2.2381
EPS:
-1.05
Net Cash Flow:
$-16.76M
1W Performance:
-1.67%
1M Performance:
-2.08%
6M Performance:
-11.65%
1Y Performance:
-9.27%
1-Day Range:
$2.34
$2.4498
1-Week Range:
$2.34
$2.565
52-Week Range:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Name
InspireMD Inc.
Sector
Industry
Phone
972 3 6917691
Address
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.35 | 100.13M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-16 | Initiated | Rodman & Renshaw | Buy |
| Mar-13-15 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-26-13 | Initiated | Oppenheimer | Outperform |
InspireMD Inc. Stock (NSPR) Latest News
Market reaction to InspireMD Inc.’s recent newsWeekly Stock Recap & Weekly Stock Performance Updates - newser.com
Detecting price anomalies in InspireMD Inc. with AIJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
Risk adjusted return profile for InspireMD Inc. analyzedTrade Entry Summary & Long-Term Safe Return Strategies - newser.com
Can InspireMD Inc. (II2) stock expand revenue streamsEarnings Recap Report & Fast Moving Stock Watchlists - newser.com
Real time breakdown of InspireMD Inc. stock performanceJuly 2025 Patterns & Technical Entry and Exit Alerts - newser.com
Technical analysis overview for InspireMD Inc. stockAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - newser.com
Is InspireMD Inc. (II2) stock among top earnings playsWeekly Trading Summary & Long-Term Investment Growth Plans - newser.com
How risky is InspireMD Inc. (II2) stock compared to peersStock Surge & AI Driven Price Predictions - newser.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
40,513 Restricted Shares: InspireMD Grants Inducements to 3 New Employees with 3-Year Vesting - Stock Titan
Sector ETF performance correlation with InspireMD Inc.July 2025 Retail & Advanced Technical Signal Analysis - newser.com
Predicting InspireMD Inc. trend using moving averagesTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com
Combining machine learning predictions for InspireMD Inc.July 2025 Price Swings & High Return Trade Guides - newser.com
Can InspireMD Inc. (II2) stock attract ESG investmentsSell Signal & Fast Exit and Entry Strategy Plans - newser.com
How to recover losses in InspireMD Inc. stockBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
How InspireMD Inc. (II2) stock reacts to stronger dollarRisk Management & Daily Risk Controlled Trade Plans - newser.com
Will InspireMD Inc. (II2) stock outperform foreign stocksBull Run & Low Drawdown Investment Ideas - newser.com
InspireMD Inc II2 Stock Analysis and ForecastGrowth Stock Opportunities & Buy Sell Signal Notifications - earlytimes.in
What high frequency data says about InspireMD Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - newser.com
InspireMD Inc. Stock (NSPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):